What is it and who is it for?
For 5 years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science business strategy, investment, partnering, deal making and commercialisation.
LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly listed life science giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.
The industry’s c-suite will be joined by the sector’s most active investors, pharma and healthtech BD&L teams, key stakeholders and top tier service companies who are moving the sector forward.
In an industry as dynamic as the life science and healthcare sector, LSX World Congress brings the people who are tackling the biggest challenges in the industry today, and helps answer the question; where to next and how do we get there?
With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, unique conference formats and a vetted, high-calibre audience, we help you Connect with purpose™.
The premier conference for leaders in life sciences, investment, technology, business and finance
CEO, Roivant Sciences
Onno Van de Stolpe
VP BD, Medtronic
VP Search & Evaluation, Novo Nordisk
VP Corporate Business Development, Eli Lilly
Managing Partner, Sofinnova
Managing Director, Inkef Capital
Former Head of EMA & Advisor, NDA
Head of BD, Europe, European Innovation Hub, MSD
VP of the Research Service Division, WuXi AppTec
Senior Director External Innovation, Eli Lilly
Senior Investment Director, M Ventures
Managing Partner, Panakes Partners
John E Milad
CEO, Quanta Dialysis
Partner, Boston Scientific
Sign up to event updates to hear about new speakers, promotions, conference news and networking events.